Skip to main content
Signal8

MCINERNEY TIMOTHY

SEC insider (Form 3/4/5 filer). CIK 0001226020. Director at Silence Therapeutics plc (SLN). 2 reported Form 4/5 transactions since Sep 2024; latest on Jan 2, 2026. Located in LONDON, X0.

Companies MCINERNEY TIMOTHY has filed insider reports for

  • Silence Therapeutics plc (SLN): Director
MCINERNEY TIMOTHY profile photo

MCINERNEY TIMOTHY

CIK: 0001226020

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Silence Therapeutics plc logo
SLN

Silence Therapeutics plc

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Silence Therapeutics plc logo
    SLN

    Silence Therapeutics plc

    Jan 2, 2026
    Award

    Share Option (Right to Buy)

    Direct
    90K shares-
  • Silence Therapeutics plc logo
    SLN

    Silence Therapeutics plc

    May 5, 2025
    Award

    Share Option (Right to Buy)

    Direct
    48K shares-

1-2 of 2